Thrilled to share our publication in @ANA_journals on insular epilepsy, a cause of surgical failures in epilepsy. We characterized the seizure semiology of the largest SEEG-confirmed cohort to date. #epilepsy Details: https://t.co/UMISTgDbyF

Another amazing #Headache Fellowship Program Director Committee meeting #ahsam2025 run by the amazing @drcarriedougherty and loaded with enthusiastic PDs! #meded @ahsheadache

The #ACNSAdvantage provides trainees access to travel grants and awards, allowing them to attend premier ACNS educational opportunities, like the Annual Meeting and Courses. Visit https://t.co/eKxj3O1Td8 to learn about Junior & Fellow Member options.

Register today for CNP Bootcamp, a seven-week program designed to introduce new fellows to the core aspects of CNP. It encompasses more than 30 hours of on-demand instruction & interactive content. Large program pricing available! https://t.co/8MTrBCkFTa

Congratulations @ACNS_org on hosting an absolutely stellar “Clinical Neurophysiology of Neurogastronomy” event! Thank you @bensalem_owen for your leadership and vision in bringing this to light! #ACNS2025 bonne dégustastion ! @ISNeurogastro

I love this so much! I’m calling on the epilepsy community to spread the word, get involved, & please share this initiative far & wide! Dr. Castellucci is seeking chefs for a keto-video cookbook 🧠 📚 @BrainAblaze @efkentuckiana @EpilepsySparks @TalkAboutItorg @PatPattrott

Why Epilepsy? 🧠 It is common (1 in 26 people in the US) 🧠 It is complex (major advances in imaging and electrophysiology) 🧠 We can help these patients! (>25 ASMs + surgical + device and other treatments) 1/

Groundbreaking news in IIH! Tirzepatide shows significant benefits in IIH treatment - 68% reduced papilledema risk, improved vision & headache outcomes. Dual GIP/GLP-1 receptor activation could offer new therapeutic approach for IIH patients independently from BMI! #IIH #Brain

A few months ago when I was completing CME for my DEA license, I thought there has to be a better way to do this If you agree, I have good news for you. Keep reading 1/3

Using clinical scenarios, @mrobbinsmd @GayleRSalama @LeviChazen share a framework of advanced clinical reasoning in the diagnosis of spinal cerebrospinal fluid leaks https://t.co/yzrXRNUB5v #CSFleak #IntracranialHypotension

Oh my! The ACNS CNP Bootcamp, a 7-week CNP online course, starts today! Did you register? 👇👇 It’s perfect for trainees! 🔥🔥🔥 The Bootcamp will cover a variety of clinical neurophysiology topics such as EEG in neonates, ICU monitoring, instrumentation, EMG/NCS, EPs 🧠

Open Access: Experts describe scenarios where #gepants can be used for situational prevention, when individuals are at heightened risk of experiencing #migraine, to prevent migraine attacks https://t.co/R9gAq55bnk @dr_j_pavlovic @daviddodick @MdBlumenfeld et al

Don't forget to register for CNP Bootcamp before sessions begin on 7/8! CNP Bootcamp is a seven-week, online program offering more than 30 hours of on-demand instruction and interactive content. CNP Bootcamp teaches the core aspects of CNP to new fellows. https://t.co/YDj3FTaDnb

The summer issue of "Clinical Neurophysiology News," the ACNS newsletter, is now available! This issue features a Call for Officer & Council Nominations, CNP Bootcamp information, an AMA House of Delegates recap, & upcoming events & programs information. https://t.co/4fpGpWQ8dR.

Registration for CNP Bootcamp is officially open! CNP Bootcamp is a seven-week, online program offering more than 30 hrs of on-demand instruction. CNP Bootcamp teaches the core aspects of CNP to new fellows in their first weeks of training. Visit https://t.co/NFUgZ6crDa

A 23 year-old woman has severe right sided headaches with ipsilateral lacrimation and conjunctival injection The attacks last 20 minutes and occur 7-8/day She’s tried >10 medications with no help, and is losing hope Is there a way to clinch the diagnosis AND help the patient?

Open Access: An animal model of #migraine suggests #onabotulinumtoxinA may play a role in migraine treatment by reducing baseline #CGRP release https://t.co/EMPg35Zb46 Philip Victor Reducha MSc et al

Key point: SISCOM localized correctly in 55% and ISAS in 65%. ISAS results were easier to interpret than SISCOM results. https://t.co/DOLW0eZbaG #epilepsysurgery #ISAS #SISCOM #SPECT #epilepsy #ILAE @IlaeWeb @epilepsiaopen @WileyNeuro

This just published online in the Headache journal. Overwhelming evidence and clinical experience supporting the use of these transformative therapies as first-line approaches.

Anti-CGRP mAbs cut workforce absenteeism & presenteeism in Spain, showing cost benefits in 3 months, even for partial responders. This challenges reimbursement policies & calls for global analyses ⭐️ #migraine